Durvalumab Regimen Improves Disease-Free Survival in High-Risk Non-Muscle-Invasive Bladder Cancer
The regimen, which consists of durvalumab and Bacillus Calmette-Guerin, offers new hope to patients with high-risk non-muscle-invasive bladder cancer.
Related Articles
GLP-1 Receptor Agonists Demonstrate Increased Risk of Neovascular Age-Related Macular Degeneration in Diabetes
Patients with diabetes using glucagon-like peptide-1 (GLP-1) drugs face double the risk of developing neovascular age-related macular degeneration, highlighting crucial ocular health concerns.
Clesrovimab Receives FDA Approval for RSV Lower Respiratory Tract Prevention in Infants
The FDA approves clesrovimab-cfor, a new RSV vaccine, offering infants effective protection against severe respiratory illness during their first RSV season.
Reimagining Pain Management: Pharmacists Urged to “Deconstruct the Cupcake”
Innovative pain management strategies emerge as experts advocate for personalized, multifaceted approaches to chronic pain, likening treatment to a tailored cupcake.
ASCO 2025: Promising Safety and Efficacy of Encorafenib and Binimetinib in Resected Stage II Melanoma
A new study reveals the combination therapy enhances safety and efficacy for high-risk BRAF-mutated stage II melanoma.
Pharmacists Take the Lead on Advanced Therapeutics
Pharmacists lead the charge in implementing advanced therapeutics, navigating complex challenges and shaping the future of health care innovation.
ASCO 2025: Vepdegestrant Shows Superiority to Fulvestrant in ER+/HER2- Advanced Breast Cancer
Vepdegestrant was the first PROTAC to be evaluated in a phase 3 clinical trial.
Ambulatory Pharmacy in Action: House Calls and Harm Reduction Clinics Expand the Reach of Care
Ambulatory pharmacists innovate care delivery, enhancing patient access and outcomes through home visits and harm reduction clinics for complex health needs.
FDA Approves First, Only Single-Pill Triple Combination for Treatment of Hypertension
The FDA has approved a groundbreaking single-pill combination therapy for hypertension, enhancing cardiovascular health with triple-agent efficacy.
Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care
Integrating specialty pharmacists into neurology teams enhances patient care, medication management, and clinical outcomes for chronic conditions.
Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment
The findings highlight the need for improved prescribing practices and patient outcomes.